Crossmark

Joint assessment of insulin resistance surrogate indices and basal metabolic rate for primary prevention of cardiometabolic multimorbidity: evidence from the China Health and Retirement Longitudinal Study (2011–2020)

Crossref DOI link: https://doi.org/10.1186/s12933-025-03067-y

Published Online: 2026-01-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lai, Hurong

Deng, Chao

Liao, Caifeng

Tian, Ruixue

Liu, Kexin

Luo, Zhangjun

He, Ling

Tu, Huaijun

Li, Jian
Funding

Funding for this research was provided by:

Internal Funding Program of the Second Affiliated Hospital of Nanchang University (2023efyB01)

National Natural Science Foundation of China (81760033)

Key Research and Development Program of Jiangxi Provincial Department of Science and Technology (20223BBG71006)
License Information

Text and Data Mining valid from 2026-01-12

Version of Record valid from 2026-02-09
More Information

Article History

Received: 11 November 2025

Accepted: 29 December 2025

First Online: 12 January 2026

Declarations

:

: The CHARLS was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Peking University (IRB00001052-11015). Written informed consent was obtained from all participants prior to their inclusion in the study.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below